Rahul Banerjee, MD, FACP

home / authors / rahul-banerjee-md

Articles

Biochemical and Clinical Progression: The Two Faces of Relapsed MM

Vivian G. Oehler, MD;Andrew J. Cowan, MD;Rahul Banerjee, MD, FACP;Paul B. Koller, MD;Lawrence W. Liu, MD;Murali Janakiram, MD, MS

September 12th 2023

Andrew Cowan, MD, discusses the complexities of relapsed multiple myeloma, distinguishing between biochemical and clinical progression, analyzing survival data, and raising questions about optimal treatment strategies.

Team Introductions: MM Experts From the Fred Hutchinson Cancer Center and City of Hope

Andrew J. Cowan, MD;Rahul Banerjee, MD, FACP;Vivian G. Oehler, MD;Paul B. Koller, MD;Lawrence W. Liu, MD;Murali Janakiram, MD, MS

September 12th 2023

An overview of the program agenda and introduction of expert panelists from the Fred Hutchinson Cancer Center and City of Hope teams.

Optimizing Ponatinib in CML: Understanding AOEs in the PACE Trial

Vivian G. Oehler, MD;Andrew J. Cowan, MD;Rahul Banerjee, MD, FACP;Paul B. Koller, MD;Lawrence W. Liu, MD;Murali Janakiram, MD, MS

September 12th 2023

A retrospective analysis of arterial occlusive events in the PACE trial, shedding light on risk factors and management strategies for ponatinib treatment in CML patients.

Team Introductions: CML Experts From the Fred Hutchinson Cancer Center and City of Hope

Vivian G. Oehler, MD;Andrew J. Cowan, MD;Rahul Banerjee, MD, FACP;Paul B. Koller, MD;Lawrence W. Liu, MD;Murali Janakiram, MD, MS

September 12th 2023

An overview of the program agenda and introduction of expert panelists from the Fred Hutchinson Cancer Center and City of Hope teams.